Andrea Veatch is an Oncology physician affiliated with Northwest Medical Specialties. OpenAlex indexes 8 publications with 414 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2920 South Meridian
Suite 100
Puyallup, WA 983731428
Telephone
253-841-4296Registry record last updated 22 Nov 2017.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- E.R. Squibb & Sons, L.L.C.Program year20251 payment
- Sumitomo Pharma America, Inc.Program year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
58.7%PD-1 inhibitor32.8%Pembrolizumab100%Part B, office-administered≥20 patientsMicrotubule Inhibitor13%Paclitaxel100%Part B, office-administered≥13 patients+ 8 more classes in this area
Metabolism & gastrointestinal
30.6%Other antiemetics26.4%Fosaprepitant100%Part B, office-administered≥34 patientsSerotonin-3 Receptor Antagonist3%Palonosetron hcl74%Ondansetron hydrochloride23%Ondansetron Odt2%Ondansetron Hcl1%Part D + Part B≥38 patients+ 6 more classes in this area
Anti-infectives
5.7%Human Immunoglobulin G5.5%Immune globulin100%Part B, office-administered≥18 patientsCephalosporin Antibacterial0.2%Ceftriaxone sodium100%Part B, office-administered≥11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- OA01.04 Five-Year Survival in Patients with ES-SCLC Treated with Atezolizumab in IMpower133: Imbrella a Extension Study Results
Journal of Thoracic Oncology
2023 - P2.07-06 Real World Efficacy of First-Line Immunotherapy +/- Chemotherapy in Advanced NSCLC Stratified by Serum Proteomics
Journal of Thoracic Oncology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
William Hirota, MD
Northwest Medical Specialties
Jorge Chaves, MD
Northwest Medical Specialties
Francis Senecal, MD
Northwest Medical Specialties
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”